| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0264-410X(02)00212-8 |
| P698 | PubMed publication ID | 12034088 |
| P2093 | author name string | Yong Xie | |
| Fion Wan-Yee Sin | |||
| Samuel Chak-Sum Cheng | |||
| Ella Wai-Ching Chan | |||
| Ho Tsun Wong | |||
| Zu Tian Sheng | |||
| P2860 | cites work | Optimisation of the immune response to foot-and-mouth disease vaccines | Q33589235 |
| Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine | Q33732770 | ||
| Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants | Q33801810 | ||
| Influence of vector-encoded cytokines on anti-Salmonella immunity: divergent effects of interleukin-2 and tumor necrosis factor alpha | Q34008045 | ||
| Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. | Q35874803 | ||
| Systemic immunological effects of cytokine genes injected into skeletal muscle | Q36302958 | ||
| Porcine interleukin 2: parameters of production and biochemical characterization. | Q39348711 | ||
| Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999). | Q40596844 | ||
| Immunology taught by viruses | Q40933905 | ||
| Gene vaccination: plasmid DNA is more than just a blueprint | Q41724485 | ||
| Cytokine adjuvancy of BVDV DNA vaccine enhances both humoral and cellular immune responses in mice | Q43032831 | ||
| Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase | Q43645495 | ||
| DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model | Q44394460 | ||
| Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection | Q45739431 | ||
| Comparison of the immune response elicited by infectious and inactivated foot-and-mouth disease virus in mice. | Q45863599 | ||
| The immune response against foot-and-mouth disease virus: influence of the T lymphocyte growth factors IL-1 and IL-2 on the murine humoral response in vivo | Q45880267 | ||
| In vivo evaluation of the effects of interleukins 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti-tumor cytotoxic T lymphocytes | Q68327269 | ||
| Combination effect of vaccination with IL2 and IL4 cDNA transfected cells on the induction of a therapeutic immune response against Lewis lung carcinoma cells | Q70550136 | ||
| Anti-metastatic vaccination of tumor-bearing mice with IL-2-gene-inserted tumor cells | Q70550141 | ||
| Novel aggregate structure adjuvants modulate lymphocyte proliferation and Th1 and Th2 cytokine profiles in ovalbumin immunized mice | Q73028963 | ||
| An immunoglobulin G based chimeric protein induced foot-and-mouth disease specific immune response in swine | Q73067810 | ||
| Coimmunization with IFN-gamma or IL-2, but not IL-13 or IL-4 cDNA can enhance Th1-type DNA vaccine-induced immune responses in vivo | Q73669406 | ||
| Chemokine gene adjuvants can modulate immune responses induced by DNA vaccines | Q73857995 | ||
| Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens | Q74442122 | ||
| P433 | issue | 21-22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | foot-and-mouth disease | Q152401 |
| P304 | page(s) | 2641-2647 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2. | |
| P478 | volume | 20 |
| Q97092977 | A ferritin nanoparticle vaccine for foot-and-mouth disease virus elicited partial protection in mice |
| Q38099839 | A review of vaccine development and research for industry animals in Korea |
| Q37373730 | Adjuvants for porcine reproductive and respiratory syndrome virus vaccines |
| Q98953662 | Adjuvants for swine vaccines: Mechanisms of actions and adjuvant effects |
| Q40533709 | An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine |
| Q97524669 | Challenges and prospects for the control of foot-and-mouth disease: an African perspective |
| Q39181986 | Co-expression of the Bcl-xL antiapoptotic protein enhances the induction of Th1-like immune responses in mice immunized with DNA vaccines encoding FMDV B and T cell epitopes |
| Q40453262 | Combined DNA vaccination against three animal viruses elicits decreased immunogenicity of a single plasmid in mice. |
| Q39273409 | Comparison of immune responses against FMD by a DNA vaccine encoding the FMDV/O/IRN/2007 VP1 gene and the conventional inactivated vaccine in an animal model. |
| Q43984177 | DNA fragment encoding human IL-1beta 163-171 peptide enhances the immune responses elicited in mice by DNA vaccine against foot-and-mouth disease |
| Q33208276 | DNA vaccines and their application against parasites--promise, limitations and potential solutions. |
| Q37143269 | DNA vaccines and their applications in veterinary practice: current perspectives |
| Q35586830 | DNA vaccines in veterinary use. |
| Q80823805 | Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost |
| Q80205526 | Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV |
| Q39976443 | Enhanced immune response of DNA vaccine (VP1-pCDNA) adsorbed on cationic PLG for foot and mouth disease in guinea pigs |
| Q35622394 | Enhanced immune response with foot and mouth disease virus VP1 and interleukin-1 fusion genes |
| Q33231691 | Enhanced immunogenicity of microencapsulated multiepitope DNA vaccine encoding T and B cell epitopes of foot-and-mouth disease virus in mice |
| Q45394430 | Enhancement of neutralizing humoral response of DNA vaccine against duck hepatitis B virus envelope protein by co-delivery of cytokine genes |
| Q45567592 | Enhancement of the immunogenicity of DNA vaccine against infectious bursal disease virus by co-delivery with plasmid encoding chicken interleukin 2. |
| Q39828923 | Enhancing immune responses against SARS-CoV nucleocapsid DNA vaccine by co-inoculating interleukin-2 expressing vector in mice |
| Q33990589 | Extract from Agaricus blazei Murill can enhance immune responses elicited by DNA vaccine against foot-and-mouth disease |
| Q34547126 | Foot-and-mouth disease |
| Q36958845 | Genetic immunization with Hantavirus vaccine combining expression of G2 glycoprotein and fused interleukin-2 |
| Q81299137 | Human papillomavirus type 16 E7 peptide(38-61) linked with an immunoglobulin G fragment provides protective immunity in mice |
| Q45710581 | Immune response in mice inoculated with plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus |
| Q43767864 | Immune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus |
| Q40416358 | Immune responses to foot-and-mouth disease DNA vaccines can be enhanced by coinjection with the Isatis indigotica extract |
| Q40133862 | Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus |
| Q35946863 | Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice |
| Q35917287 | New approaches to rapidly control foot-and-mouth disease outbreaks |
| Q43969765 | Optimization strategy for plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus by cis-expression with IL-2. |
| Q42280748 | Oral immunization of mice using Bifidobacterium longum expressing VP1 protein from enterovirus 71. |
| Q51973276 | Porcine B-cell activating factor promotes anti-FMDV antibodies in vitro but not in vivo after DNA vaccination of pigs. |
| Q38597798 | Positive effects of porcine IL-2 and IL-4 on virus-specific immune responses induced by the porcine reproductive and respiratory syndrome virus (PRRSV) ORF5 DNA vaccine in swine |
| Q45423884 | Positive inductive effect of IL-2 on virus-specific cellular responses elicited by a PRRSV-ORF7 DNA vaccine in swine |
| Q38006997 | Progress in the development of DNA vaccines against foot-and-mouth disease |
| Q41995734 | Recombinant adenovirus expressing the haemagglutinin of Peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR. |
| Q42236079 | The expression of IL6 and 21 in crossbred calves upregulated by inactivated trivalent FMD vaccine. |
| Q45424332 | Tissue distribution of a plasmid DNA containing epitopes of foot-and-mouth disease virus in mice |
| Q37403499 | Vaccination against foot-and-mouth disease virus: strategies and effectiveness |
Search more.